Bioactive Compound Details

BioIDbio3075
NameREVEFENACIN
ChEMBL IDCHEMBL3833319
Molecular FormulaC35H43N5O4
Molecular Weight597.76
Molecular Weight (Monoisotopic)597.3315
TypeSmall molecule
Max PhasePhase 4
Target IDTar12
Target NameToll-like receptor 9 (TLR9)
SynonymsGSK-1160724|GSK1160724|REVEFENACIN|REVEFENACINA|REVEFENACINE|TD-4208|YUPELRI
SmilesCN(CCN1CCC(OC(=O)Nc2ccccc2-c2ccccc2)CC1)C(=O)c1ccc(CN2CCC(C(N)=O)CC2)cc1
InchiInChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)
Inchi KeyFYDWDCIFZSGNBU-UHFFFAOYSA-N
Molecular SpeciesBASE
Targets33.0
Bioactivities66.0
Np Likeness Score-1.3
Records Key['REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'Example-1', 'REVEFENACIN', 'EUB0000925a', 'EUB0000925a', 'EUB0000925a', 'EUB0000925a', 'EOS100079']
Records Name['REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'REVEFENACIN', 'Biphenyl-2-ylcarbamic Acid 1-(2-{[4-(4-Carbamoylpiperidin-1-ylmethyl)benzoyl]methylamino}ethyl)piperidin-4-yl Ester', 'REVEFENACIN', 'Revefenacin', 'Revefenacin', 'Revefenacin', 'Revefenacin', 'REVEFENACIN']
Withdrawn FlagFalse
Orphan0

Molecular Structure

2D Molecular Structure